Dementia will cost over 1 per cent of world’s GDP: study - Macleans.ca
 

Dementia will cost over 1 per cent of world’s GDP: study

Costs will exceed revenue of Wal-Mart or Exxon Mobil


 

Costs associated with dementia will total over 1 per cent of the world’s gross domestic product this year, coming in at over $604 billion. This poses the most significant health and social crisis of the century, notes the World Alzheimer Report, adding that the cost will exceed the revenue of Wal-Mart or Exxon Mobil. Investment in care and treatment is needed, campaigners say, noting that investing now will reduce the burden in the future. A large part of the issue is rising life expectancy, and as people live longer, more people will develop dementia. The number of people with dementia is expected to double by 2030, and triple by 2050.

BBC News


 
Filed under:

Dementia will cost over 1 per cent of world’s GDP: study

  1. Why not promote Vitamin B's then? It's the only thing being researched that does more to combat this illness than anything out there. Unless, medical physicians and pharmas are so unhappy for it would not bring them that much money than prescription drugs?